Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q1)
Portfolio Summary: 83 holdings with a total value of $1,283,593,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HORIZON PHARMA PLC 7,053,504 183,179,000 14.27%
2 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,719,959 84,865,000 6.61%
3 RETROPHIN INC COM 2,962,298 70,977,000 5.53%
4 AEGERION PHARMACEUTICALS INC 2,502,578 65,492,000 5.10%
5 PROGENICS PHARMACEUTICALS IN 8,951,169 53,528,000 4.17%
6 EMERGENT BIOSOLUTIONS INC COM 1,810,519 52,071,000 4.06%
7 ANGIODYNAMICS INC 2,398,527 42,670,000 3.32%
8 HERON THERAPEUTICS INC 2,808,173 40,859,000 3.18%
9 AMPHASTAR PHARMACEUTICALS IN COM 2,127,854 31,833,000 2.48%
10 RIGEL PHARMACEUTICAL INC 8,246,329 29,439,000 2.29%
11 BioDelivery Sciences International Inc 2,246,399 23,587,000 1.84%
12 PERNIX THERAPEUTICS HLDGS IN 2,168,326 23,179,000 1.81%
13 ALERE INC 452,423 22,123,000 1.72%
14 IDERA PHARMACEUTICALS INC 5,663,845 21,013,000 1.64%
15 ARATANA THERAPEUTICS INC COM 1,131,865 18,121,000 1.41%
16 DERMA SCIENCES INC COM PAR .01 2,130,477 18,045,000 1.41%
17 CATALYST PHARMACEUTICALS INC 4,083,177 17,680,000 1.38%
18 IGNYTA INC COM 1,741,700 17,330,000 1.35%
19 DYNAVAX TECHNOLOGIES CORP 766,010 17,182,000 1.34%
20 DEPOMED INC 705,204 15,804,000 1.23%
21 ZOGENIX INC 10,737,645 14,711,000 1.15%
22 HORIZON PHARMA PLC 500,000 12,985,000 1.01% Call
23 LA JOLLA PHARMACEUTICAL CO 703,470 12,874,000 1.00%
24 Lion Biotechnologies 1,062,419 12,866,000 1.00%
25 SOCIETAL CDMO INC 1,413,533 12,821,000 1.00%
26 ANTARES PHARMA INC 4,700,000 12,737,000 0.99%
27 SYNERON MEDICAL LTD ORD SHS 1,005,221 12,445,000 0.97%
28 GENOCEA BIOSCIENCES INC 1,035,000 12,275,000 0.96%
29 UNIVERSAL AMERN CORP NEW 1,133,989 12,111,000 0.94%
30 ADVAXIS INC COM NEW 805,994 11,639,000 0.91%
31 CORIUM INTERNATIONAL INC 1,736,736 11,376,000 0.89%
32 RETROPHIN INC COM 500,000 11,198,000 0.87% Call
33 ATRICURE INC 533,354 10,928,000 0.85%
34 ANTHERA PHARMACEUTICALS I 2,420,457 10,819,000 0.84%
35 VERASTEM INC COM 1,050,000 10,679,000 0.83%
36 Anacor Pharmaceuticals Inc 184,320 10,663,000 0.83%
37 DISCOVERY LABORATORIES INC N 8,072,500 9,606,000 0.75%
38 ADMA BIOLOGICS, INC. 964,193 9,449,000 0.74%
39 TREVENA INC 1,409,153 9,188,000 0.72%
40 MIRATI THERAPEUTICS INC COM 306,463 8,985,000 0.70%
41 ALCOBRA LTD 1,556,016 8,760,000 0.68%
42 ELEVEN BIOTHERAPEUTICS INC 966,057 8,617,000 0.67%
43 MEDGENICS INC 1,025,000 8,262,000 0.64%
44 IGI LABS INC 1,000,000 8,160,000 0.64%
45 PARATEK PHARMACEUTICALS INC 260,283 8,136,000 0.63%
46 FLEXION THERAPEUTICS INC COM 348,204 7,842,000 0.61%
47 DURECT CORP 3,904,495 7,458,000 0.58%
48 TONIX PHARMACEUTICALS HLD 1,176,639 7,436,000 0.58%
49 Redhill Biopharma Ltd 484,281 7,046,000 0.55%
50 EPIRUS BIOPHARMA 775,000 6,936,000 0.54%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-15-004356, filed 2015.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.